Korro Bio, Inc.

KRRO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$18-$26-$23-$21
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$2$3-$4$11
Other Non-Cash$2$2$2$1
Operating Cash Flow-$17-$19-$24-$7
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$15-$11$0-$28
Inv. Sales/Matur.$23$0$33$27
Other Inv. Act.$0$0$0$0
Investing Cash Flow$8-$11$33-$3
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$1
Forex Effect-$0$1$0-$0
Net Chg. in Cash-$9-$30$9-$9
Supplemental Information
Beg. Cash$35$64$56$65
End Cash$25$35$64$56
Free Cash Flow-$17-$19-$25-$9
Korro Bio, Inc. (KRRO) Financial Statements & Key Stats | AlphaPilot